bluebird bio, Inc. Payment for Contingent Consideration Liability, Financing Activities
bluebird bio, Inc. reported Payment for Contingent Consideration Liability, Financing Activities of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities · last filed 2020-02-18
- bluebird bio, Inc. payment for contingent consideration liability, financing activities for the quarter ending 2017-12-31 was $0.00.
- bluebird bio, Inc. payment for contingent consideration liability, financing activities for the quarter ending 2016-12-31 was $0.00.
- bluebird bio, Inc. payment for contingent consideration liability, financing activities for the quarter ending 2016-09-30 was $0.00.
- bluebird bio, Inc. payment for contingent consideration liability, financing activities for fiscal 2019 was $0.00.
- bluebird bio, Inc. payment for contingent consideration liability, financing activities for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- bluebird bio, Inc. payment for contingent consideration liability, financing activities for fiscal 2017 was $1.07M, a 46.96% decline from fiscal 2016.
- bluebird bio, Inc. payment for contingent consideration liability, financing activities for fiscal 2016 was $2.02M, a 347.02% increase from fiscal 2015.
| Period end | Payment for Contingent Consideration Liability, Financing Activities 3 month | Payment for Contingent Consideration Liability, Financing Activities 6 month | Payment for Contingent Consideration Liability, Financing Activities 9 month | Payment for Contingent Consideration Liability, Financing Activities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-18 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-18 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $1.07M 10-K · filed 2020-02-18 | ||
| 2017-09-30 | $1.07M 10-Q · filed 2018-11-01 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 derived: sum of 2 quarters · filed 2019-02-21 | $2.02M 10-K · filed 2019-02-21 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $2.02M 10-Q · filed 2017-11-01 | ||
| 2016-06-30 | $2.02M 10-Q · filed 2017-08-02 | |||
| 2015-12-31 | $453.00K 10-K · filed 2018-02-21 |